Back to News
Market Impact: 0.1
Royalty Pharma declares fourth quarter 2026 dividend
Source: globenewswire.com
Capital Returns (Dividends / Buybacks)
Royalty Pharma’s board approved a fourth-quarter 2026 dividend of $0.235 per Class A ordinary share. The brief dividend announcement provides no additional payout or market-reaction details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
RPRX0.30
More News
- Why is Suncor Energy stock climbing today?
- Top 5 Canadian Mining Stocks This Week: Lithium Africa Rises Over 50 Percent on Assay Results
- Halfway Through October, Diesel Is Setting the Terms for the Entire Energy Market
- China’s CXMT swings to a nearly $20B profit as memory prices soar
- Raymond James upgrades Greif stock on margin expansion outlook
- Strategy stock (MSTR) falls as MSCI index exclusion threatens passive investments